Our prospective observational cohort study of patients with DM initiating dialysis treatment considered the entire information collected on HbA1c over a period of more than seven years and observed a significant association between low HbA1c levels and all-cause mortality.
We observed a significant correlation between low SOCS6 levels and elevated AREG mRNA levels in CRC.
Correlations between low BRCA1 levels, tumour grade, metastasis and prognostic markers such as oestrogen receptor status have also been made [ 16, 17].
These findings provide a potential mechanistic basis for the frequently observed association between low 25D levels and poor outcomes in critically ill patients.
These findings provide a potential mechanistic basis for the commonly observed association between low 25D levels and poor outcomes in critically ill patients.
However, we could not validate the association between low STMN1 levels and increased cisplatin sensitivity in muscle-invasive bladder cancer, which is in concordance with the results in a lung cancer study (Jiang et al, 2013).
Observational studies have revealed a connotation between low 25(OH)D3 level and stroke, myocardial infarction, hypertensive heart disease, obesity, dyslipidemia, and diabetes mellitus [64, 65, 66, 67].
Taken together, these analyses of luminal BrCa biopsies show a strong correlation between low p53 expression levels and elevated levels of Mdm proteins.
An association between risk genotypes and low C3 levels was also observed (P = 0.034).
Of equal importance, the majority of patient samples on a colon cancer tissue microarray displayed an inverse correlation between high YAP1 and low NDR2 levels.
